Belleville, WI, United States of America

Amy Jo Miyamoto

USPTO Granted Patents = 2 

Average Co-Inventor Count = 4.2

ph-index = 1

Forward Citations = 6(Granted Patents)


Company Filing History:


Years Active: 2012-2022

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Amy Jo Miyamoto: Innovator in Plant Transformation

Introduction

Amy Jo Miyamoto is a notable inventor based in Belleville, Wisconsin. She has made significant contributions to the field of plant transformation, holding 2 patents that showcase her innovative methods and techniques. Her work focuses on enhancing the production of value-added explants and developing transgenic plants.

Latest Patents

Miyamoto's latest patents include an "Efficient Plant Transformation Method," which discloses methods for producing value-added explants from the seeds of dicotyledonous cultivars. This patent outlines transformation methods using the value-added explants produced by her innovative techniques. Another significant patent is related to "Shade Regulatory Regions," which describes regulatory regions suitable for directing the expression of heterologous polynucleotides under specific light conditions. This patent also includes nucleic acid constructs and methods for producing transgenic plants that contain these constructs.

Career Highlights

Throughout her career, Amy Jo Miyamoto has worked with prominent organizations such as Ceres, Inc. and the Wisconsin Alumni Research Foundation. Her experience in these companies has allowed her to develop and refine her expertise in plant transformation technologies.

Collaborations

Miyamoto has collaborated with notable colleagues, including Shing Kwok and Kenneth Bounds, who have contributed to her research and development efforts in the field.

Conclusion

Amy Jo Miyamoto's innovative work in plant transformation has led to significant advancements in the field, as evidenced by her patents and collaborations. Her contributions continue to influence the development of transgenic plants and agricultural biotechnology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…